Evidence map›Paper›PMID 31082331›Full record

SynthesisEmerging infectious diseases2019

Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era.

Ananda S Bandyopadhyay, Harpal Singh, Jacqueline Fournier-Caruana, John F Modlin, Jay Wenger, Jeffrey Partridge, Roland W Sutter, Michel J Zaffran

Abstract readMeta-Analysis
In one paragraph

Synthesis in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ananda S Bandyopadhyay
Harpal Singh
Jacqueline Fournier-Caruana
John F Modlin
Jay Wenger
Jeffrey Partridge
Roland W Sutter
Michel J Zaffran

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Polio Eradication Initiative continues to make progress toward the eradication target. Indigenous wild poliovirus (WPV) type 2 was last detected in 1999, WPV type 3 was last detected in 2012, and over the past 2 years WPV type 1 has been detected only in parts of 2 countries (Afghanistan and Pakistan). Once the eradication of poliomyelitis is achieved, infectious and potentially infectious poliovirus materials retained in laboratories, vaccine production sites, and other storage facilities will continue to pose a risk for poliovirus reintroduction into communities. The recent breach in containment of WPV type 2 in an inactivated poliovirus vaccine manufacturing site in the Netherlands prompted this review, which summarizes information on facility-associated release of polioviruses into communities reported over >8 decades. Successful polio eradication requires the management of poliovirus containment posteradication to prevent the consequences of the reestablishment of poliovirus transmission.

Indexed as

PoliovirusAnimalsBiohazard ReleaseDisease EradicationGlobal HealthHumansLaboratoriesPoliomyelitisPoliovirus Vaccine, InactivatedPoliovirus Vaccine, OralPoliovirus Vaccine, InactivatedPoliovirus Vaccine, Oralaccidental releasebiologicalcontainmentlaboratory infectionspoliopoliomyelitispoliovirusreemerging infectious diseasevaccine-preventable diseasesviruses

Identifiers

PMID31082331
PMCPMC6590745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.